Wuhan Keqian Biology Co Ltd (688526) — Financial Flexibility Index
Wuhan Keqian Biology Co Ltd (688526) has a Financial Flexibility Index of 0.32x as of September 2025. Free cash flow of CN¥185.71 Million (operating CF CN¥174.36 Million minus capex CN¥11.35 Million) represents 0% of total liabilities (CN¥580.21 Million). Also explore Wuhan Keqian Biology Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Keqian Biology Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Wuhan Keqian Biology Co Ltd across 9 annual periods. Check 688526 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Wuhan Keqian Biology Co Ltd. For the full company profile including market capitalisation, see 688526 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.90x | CN¥499.63 Million | CN¥392.68 Million | CN¥552.80 Million | ▲ +17.3% |
| 2023 | 0.77x | CN¥642.54 Million | CN¥538.03 Million | CN¥833.59 Million | ▲ +30.5% |
| 2022 | 0.59x | CN¥526.56 Million | CN¥423.71 Million | CN¥891.63 Million | ▼ -62.7% |
| 2021 | 1.59x | CN¥905.72 Million | CN¥531.27 Million | CN¥571.41 Million | ▲ +24.6% |
| 2020 | 1.27x | CN¥511.73 Million | CN¥400.14 Million | CN¥402.40 Million | ▲ +9.7% |
| 2019 | 1.16x | CN¥292.62 Million | CN¥154.89 Million | CN¥252.48 Million | ▲ +6.9% |
| 2018 | 1.08x | CN¥383.26 Million | CN¥351.83 Million | CN¥353.51 Million | ▼ -39.9% |
| 2017 | 1.80x | CN¥466.73 Million | CN¥337.61 Million | CN¥258.86 Million | ▲ +29.2% |
| 2016 | 1.40x | CN¥249.82 Million | CN¥220.69 Million | CN¥179.01 Million | — |